WAGGONER KENNETH L.

PrivateCIK: 1464611
Location

IRVINE, CA

WAGGONER KENNETH L. enters PHARMACYTE BIOTECH, INC. with 20.60K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderWAGGONER KENNETH L.CIK 1464611
→
IssuerPHARMACYTE BIOTECH, INC.CIK 1157075
DirectorOfficer· Chairman, CEO, Pres and GC
Since Aug 2021
20.60K
Baseline shares
100% direct
20.60K
Direct ownership
1 position
15K
Derivative underlying
5 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned20.60K
Total
20.60K direct20.60K
Derivative Holdings5

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

3K

Shares owned

N/A

Exercise price

61.20

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

3K

Shares owned

N/A

Exercise price

83.70

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

3K

Shares owned

N/A

Exercise price

74.25

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

3K

Shares owned

N/A

Exercise price

156.00

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

3K

Shares owned

N/A

Exercise price

10.05

Expiration

—

Exercise window

—

Total

Underlying

15K

Owned

0.00